Cargando…
Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis
BACKGROUND: Kinases are key mediators of inflammation, highlighting the potential of kinase inhibitors as treatments for inflammatory disorders. Selective kinase inhibitors, however, have proved disappointing, particularly in the treatment of rheumatoid arthritis and inflammatory bowel disease. Cons...
Autores principales: | Biancheri, Paolo, Foster, Martyn R., Fyfe, Matthew C. T., MacDonald, Thomas T., Sirohi, Sameer, Solanke, Yemisi, Wood, Eleanor, Rowley, Adele, Webber, Steve, Walshe, Claire A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869561/ https://www.ncbi.nlm.nih.gov/pubmed/27104822 http://dx.doi.org/10.1097/MIB.0000000000000759 |
Ejemplares similares
-
Fecal microbiota in pouchitis and ulcerative colitis
por: Li, Kai-Yu, et al.
Publicado: (2016) -
A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
por: Taylor, Mike, et al.
Publicado: (2019) -
Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses
por: Shi, Lei, et al.
Publicado: (2020) -
Herb-partitioned moxibustion alleviates colon injuries in ulcerative colitis rats
por: Zhang, Dan, et al.
Publicado: (2018) -
VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice
por: Wang, Chun-Sai-Er, et al.
Publicado: (2018)